(Q40119371)

17 September 2017

title

Iron stimulates urokinase plasminogen activator expression and activates NF-kappa B in human prostate cancer cells (English)

1 reference

17 September 2017

1 reference

1 reference

Deborah L Ornstein

1

1 reference

17 September 2017

Leo R Zacharski

series ordinal

2

1 reference

17 September 2017

publication date

1 January 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

58

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

115-126

1 reference

Prevention of prostate-cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA).

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

A labile repressor acts through the NFkB-like binding sites of the human urokinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Iron, lipids, and risk of cancer in the Framingham Offspring cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Signaling role of intracellular iron in NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Ultraviolet a radiation-induced immediate iron release is a key modulator of the activation of NF-kappaB in human skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Iron, lactoferrin and iron regulatory protein activity in the synovium; relative importance of iron loading and the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Anti-HIV effect of iron chelators: different mechanisms involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Quantitation of intracellular oxidation in a renal epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Arsenic induces oxidant stress and NF-KB activation in cultured aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Expression and activity of urokinase and its receptor in endothelial and pulmonary epithelial cells exposed to asbestos

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

The urokinase-type plasminogen activator system in prostate cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Cancer treatment with inhibitors of urokinase-type plasminogen activator and plasmin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Induction of urinary plasminogen activator by retinoic acid results in increased invasiveness of human prostate cancer cells PC-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Regulation of u-PA gene expression in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Regulation of ferritin genes and protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

The uptake of inorganic iron complexes by human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Post-transcriptional regulation of plasminogen activator inhibitor-1 by intracellular iron in cultured human lung fibroblasts--interaction of an 81-kDa nuclear protein with the 3'-UTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Iron-mediated stability of PAI-1 mRNA in adenocarcinoma cells-involvement of a mRNA-binding nuclear protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

The role of constitutive NF-kappaB activity in PC-3 human prostate cancer cell invasive behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Idoxifene and estradiol enhance antiapoptotic activity through estrogen receptor-beta in cultured rat hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Translocation of Bax in rat hepatocytes cultured with ferric nitrilotriacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Role of non-transferrin bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Non-transferrin-bound iron in the serum of hemodialysis patients who receive ferric saccharate: no correlation to peroxide generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Cell permeable iron chelators as potential cancer chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Molecular mechanisms of iron uptake by cells and the use of iron chelators for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

A phase II trial of deferoxamine in patients with hormone-refractory metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Recent insights into interactions of deferoxamine with cellular and plasma iron pools: Implications for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Activation of NF-κB by PM10 Occurs via an Iron-Mediated Mechanism in the Absence of IκB Degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Nuclear Factor- B Nuclear Localization Is Predictive of Biochemical Recurrence in Patients with Positive Margin Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

Expression of NF-?B in prostate cancer lymph node metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635580701308265

10.1080/01635580701308265

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference